Table 3 Findings of two-sample MR investigating effects of genetically predicted GrimAA on cognitive function based on primary method and pleiotropy-robust methods

From: Epigenetic age acceleration and midlife cognition: joint evidence from observational study and Mendelian randomization

Outcome

Exposure genetic instruments

Primary analysis

Sensitivity analysis

Egger intercept P

Method

Effecta (95% CI)

Pb

Method

Effecta (95% CI)

P

Trail making tests

GrimAA 4 SNPs

0.34

IVW

0.024 (0 to 0.049)

0.05

Weighted median

0.015 (−0.015 to 0.045)

0.32

Parts A (N = 99,479)

Weighted mode

0.014 (−0.031 to 0.059)

0.59

Trail making tests

GrimAA 4 SNPs

0.54

IVW

0.022 (−0.015 to 0.059)

0.25

Weighted median

0.011 (−0.021 to 0.043)

0.49

Parts B (N = 99,477)

Weighted mode

0.007 (−0.043 to 0.058)

0.79

Numeric memory (N = 106,162)

GrimAA 4 SNPs

0.55

IVW

0.97 (0.94 to 1.01)

0.14

Weighted median

0.98 (0.94 to 1.02)

0.31

Weighted mode

0.98 (0.93 to 1.04)

0.61

  1. CI confidence interval, IVW inverse variance-weighted, SNP single nucleotide polymorphism.
  2. aEffect is per 1-year increase of EAA. Effects for trail making tests are β coefficients based on the GWAS using inverse rank normal transformed duration to complete path. Effect for numeric memory is odds ratio based on the GWAS using maximum digits remembered correctly that is modeled as ordered categorical variable.
  3. bAll p-values reported are unadjusted for multiple comparisons.